Literature DB >> 23908327

Can we do better than dobutamine?

Elizabeth M McNally1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23908327      PMCID： PMC3869564          DOI： 10.1161/CIRCRESAHA.113.302000

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  10 in total

Review 1.  Inotropic therapy for heart failure: an evidence-based approach.

Authors:  G M Felker; C M O'Connor
Journal:  Am Heart J       Date:  2001-09       Impact factor: 4.749

2.  The price of innovation: new estimates of drug development costs.

Authors:  Joseph A DiMasi; Ronald W Hansen; Henry G Grabowski
Journal:  J Health Econ       Date:  2003-03       Impact factor: 3.883

3.  Placing a value on new technologies.

Authors:  Paul A Heidenreich
Journal:  Circulation       Date:  2013-05-22       Impact factor: 29.690

Review 4.  Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease.

Authors:  Christopher B Overgaard; Vladimír Dzavík
Journal:  Circulation       Date:  2008-09-02       Impact factor: 29.690

Review 5.  Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-01-01       Impact factor: 29.690

6.  Alpha-adrenergic receptor identification by (3H)dihydroergocryptine binding.

Authors:  L T Williams; R J Lefkowitz
Journal:  Science       Date:  1976-05-21       Impact factor: 47.728

7.  Stereospecific (3H)(minus)-alprenolol binding sites, beta-adrenergic receptors and adenylate cyclase.

Authors:  R J Lefkowitz; C Mukherjee; M Coverstone; M G Caron
Journal:  Biochem Biophys Res Commun       Date:  1974-09-23       Impact factor: 3.575

8.  Adrenergic receptors: a personal and practical view.

Authors:  R P Ahlquist
Journal:  Perspect Biol Med       Date:  1973       Impact factor: 1.416

9.  Dobutamine: development of a new catecholamine to selectively increase cardiac contractility.

Authors:  R R Tuttle; J Mills
Journal:  Circ Res       Date:  1975-01       Impact factor: 17.367

10.  Differentiation of receptor systems activated by sympathomimetic amines.

Authors:  A M Lands; A Arnold; J P McAuliff; F P Luduena; T G Brown
Journal:  Nature       Date:  1967-05-06       Impact factor: 49.962
  10 in total
  1 in total

1.  The apelinergic system as an alternative to catecholamines in low-output septic shock.

Authors:  David Coquerel; Xavier Sainsily; Lauralyne Dumont; Philippe Sarret; Éric Marsault; Mannix Auger-Messier; Olivier Lesur
Journal:  Crit Care       Date:  2018-01-19       Impact factor: 9.097
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.